Home page Home page

Sildenafil Teva
sildenafil

Package leaflet: Information for the patient


Sildenafil Teva 25 mg film-coated tablets

sildenafil


Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

Very common (may affect more than 1 in 10 people): headache


Common (may affect up to 1 in 10 people): nausea, facial flushing, hot flush (symptoms include a sudden feeling of heat in your upper body), indigestion, colour tinge to vision, blurred vision, visual disturbance, stuffy nose and dizziness.


Uncommon (may affect up to 1 in 100 people): vomiting, skin rash, eye irritation, bloodshot eyes /red eyes, eye pain, seeing flashes of light, visual brightness, light sensitivity, watery eyes, pounding heartbeat, rapid heartbeat, high blood pressure, low blood pressure, muscle pain, feeling sleepy, reduced sense of touch, vertigo, ringing in the ears, dry mouth, blocked or stuffy sinuses, inflammation of the lining of the nose (symptoms include runny nose, sneezing and stuffy nose), upper abdominal pain, gastro-oesophageal reflux disease (symptoms include heartburn), presence of blood in urine, pain in the arms or legs, nosebleed, feeling hot and feeling tired.

Rare (may affect up to 1 in 1,000 people): fainting, stroke, heart attack, irregular heartbeat, temporary decreased blood flow to parts of the brain, feeling of tightening of the throat, numb mouth, bleeding at the back of the eye, double vision, reduced sharpness of vision, abnormal sensation in the eye, swelling of the eye or eyelid, small particles or spots in your vision, seeing halos around lights, dilation of the pupil of the eye, discolouration of the white of the eye, penile bleeding, presence of blood in semen, dry nose, swelling of the inside of the nose, feeling irritable and sudden decrease or loss of hearing.


From post-marketing experience cases of unstable angina (a heart condition) and sudden death have been reported rarely. Of note, most, but not all, of the men who experienced these side effects had heart problems before taking this medicine. It is not possible to determine whether these events were directly related to sildenafil.


Reporting of side effects

image

If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.


  1. How to store Sildenafil Teva


    Keep this medicine out of the sight and reach of children.


    Do not use this medicine after the expiry date which is stated on the blister and carton after EXP. The expiry date refers to the last day of that month.


    Store in the original package, in order to protect from moisture.


    Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.


  2. Contents of the pack and other information What Sildenafil Teva contains

The active substance is sildenafil. Each tablet contains 25 mg of sildenafil (as the citrate salt).


The other ingredients are:

Tablet core: microcrystalline cellulose, calcium hydrogen phosphate, croscarmellose sodium, magnesium stearate.

Film coat: poly(vinyl alcohol), titanium dioxide (E171), macrogol 3350, talc.


What Sildenafil Teva looks like and contents of the pack

Sildenafil Teva 25 mg are white, oval-shaped film-coated tablets, engraved with ‘S 25’ on one side, and plain on the other side.

Sildenafil Teva is available in blister packs of 2, 4, 8 and 12 tablets, and perforated unit dose blisters containing 10 x 1 tablet.


Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer Marketing Authorisation Holder

Teva B.V.

Swensweg 5

2031GA Haarlem The Netherlands


Manufacturer:

TEVA Pharmaceutical Works Private Limited Company Pallagi út 13

4042 Debrecen Hungary


Teva Pharma, S.L.U.

Polígono Industrial Malpìca, calle C,no.4 50016 Zaragoza

Spain


Teva Operations Poland Sp.z.o.o. ul Mogilska 80. 31-546, Krakow, Poland


For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:


België/Belgique/Belgien

Teva Pharma Belgium N.V./S.A./AG Tél/Tel: +32 38207373

Lietuva

UAB Teva Baltics Tel: +370 52660203


България

Тева Фарма ЕАД Тел: +359 24899585

Luxembourg/Luxemburg ratiopharm GmbH Allemagne/Deutschland Tél/Tel: +49 73140202


Česká republika

Teva Pharmaceuticals CR, s.r.o. Tel: +420 251007111

Magyarország

Teva Gyógyszergyár Zrt. Tel: +36 12886400


Danmark

Teva Denmark A/S Tlf: +45 44985511

Malta

Teva Pharmaceuticals Ireland L-Irlanda

Tel: +44 2075407117


Deutschland

TEVA GmbH

Tel: +49 73140208

Nederland

Teva Nederland B.V. Tel: +31 8000228400


Eesti

UAB Teva Baltics Eesti filiaal Tel: +372 6610801

Norge

Teva Norway AS Tlf: +47 66775590


Ελλάδα

Specifar Α.Β.Ε.Ε. Τηλ: +30 2118805000

Österreich

ratiopharm Arzneimittel Vertriebs-GmbH Tel: +43 1970070


España

Teva Pharma, S.L.U. Tel: +34 913873280

Polska

Teva Pharmaceuticals Polska Sp. z o.o. Tel: +48 223459300


France

Teva Santé

Portugal

Teva Pharma - Produtos Farmacêuticos, Lda.

Tél: +33 155917800 Tel: +351 214767550


Hrvatska

Pliva Hrvatska d.o.o. Tel: +385 13720000

România

Teva Pharmaceuticals S.R.L Tel: +40 212306524


Ireland

Teva Pharmaceuticals Ireland Tel: +44 2075407117

Slovenija

Pliva Ljubljana d.o.o. Tel: +386 15890390


Ísland

Teva Pharma Iceland ehf. Sími: +354 5503300

Slovenská republika

TEVA Pharmaceuticals Slovakia s.r.o. Tel: +421 257267911


Italia

Teva Italia S.r.l. Tel: +39 028917981

Suomi/Finland

Teva Finland Oy

Puh/Tel: +358 201805900


Κύπρος

Specifar Α.Β.Ε.Ε. Ελλάδα

Τηλ: +30 2118805000

Sverige

Teva Sweden AB Tel: +46 42121100


Latvija

UAB Teva Baltics filiāle Latvijā

Tel: +371 67323666

United Kingdom (Northern Ireland)

Teva Pharmaceuticals Ireland Ireland

Tel: +44 2075407117


This leaflet was last revised in